 Download |
CHANGES IN EQUITY-ACCOUNTED INVESTMENTS |
||||||
|---|---|---|---|---|---|---|
€ million |
Equity accounted investments |
Other equity investments |
Total |
|||
Cost Balance at Jan. 1, 2007 |
7,020 |
613 |
7,633 |
|||
Foreign exchange differences |
–18 |
–1 |
–19 |
|||
Changes in consolidated Group |
– |
0 |
0 |
|||
Additions |
1,904 |
438 |
2,342 |
|||
Transfers |
–10 |
10 |
– |
|||
Disposals |
883 |
159 |
1,042 |
|||
Reversal of impairment losses |
– |
– |
– |
|||
Balance at Dec. 31, 2007 |
8,013 |
901 |
8,914 |
|||
Impairment losses |
144 |
203 |
347 |
|||
Foreign exchange differences |
–1 |
0 |
–1 |
|||
Changes in consolidated Group |
– |
– |
– |
|||
Additions to cumulative |
78 |
174 |
252 |
|||
Transfers |
–3 |
3 |
– |
|||
Disposals |
– |
27 |
27 |
|||
Reversal of impairment losses |
– |
– |
– |
|||
Balance at Dec. 31, 2007 |
218 |
353 |
571 |
|||
Carrying amount at Dec. 31, 2007 |
7,795 |
548 |
8,343 |
|||
| Download |
CHANGES IN EQUITY-ACCOUNTED INVESTMENTS |
||||||
|---|---|---|---|---|---|---|
€ million |
Equity accounted investments |
Other equity investments |
Total |
|||
Cost Balance at Jan. 1, 2008 |
8,013 |
901 |
8,914 |
|||
Foreign exchange differences |
47 |
2 |
49 |
|||
Changes in consolidated Group |
–1,518 |
–229 |
–1,747 |
|||
Additions |
979 |
194 |
1,173 |
|||
Transfers |
–7 |
7 |
– |
|||
Disposals |
1,120 |
5 |
1,125 |
|||
Reversal of impairment losses |
– |
– |
– |
|||
Balance at Dec. 31, 2008 |
6,394 |
870 |
7,264 |
|||
Impairment losses |
218 |
353 |
571 |
|||
Foreign exchange differences |
18 |
0 |
18 |
|||
Changes in consolidated Group |
– |
–98 |
–98 |
|||
Additions to cumulative |
– |
32 |
32 |
|||
Transfers |
– |
– |
– |
|||
Disposals |
109 |
0 |
109 |
|||
Reversal of impairment losses |
–106 |
– |
–106 |
|||
Balance at Dec. 31, 2008 |
21 |
287 |
308 |
|||
Carrying amount at Dec. 31, 2008 |
6,373 |
583 |
6,956 |
|||
Equity-accounted investments include joint ventures in the amount of €2,980 million (previous year: €2,789 million).
As a result of improved earnings prospects, impairment losses amounting to €106 million on several joint ventures attributable to the Automotive Division that were recognized in previous years were reversed in the past fiscal year. Value in use was estimated using a discount factor of 9.4% (previous year: 13%).
Significant joint ventures and associates are detailed in the listing of significant Group companies at the end of the notes to the consolidated financial statements.
